RCM
BIND

Rotella Capital Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Rotella Capital Management’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-19,000
Closed -$106K – 776
2015
Q2 		$106K Buy
+19,000
New +$118K 0.09% 268

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rotella Capital Management's BIND Position: Q3 2015 in Review

Rotella Capital Management sold out of BIND THERAPEUTICS INC (BIND) in Q3 2015, closing a stake of 19,000 shares — an estimated $106K sold.

Rotella Capital Management first reported a position in BIND in Q2 2015 and held it in 1 quarter. The position peaked at $106K in Q2 2015. 33 funds tracked by Wall St. Rank hold BIND as of Q3 2015.

  • Rotella Capital Management reported no remaining BIND THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
  • Rotella Capital Management sold 19,000 BIND THERAPEUTICS INC shares in Q3 2015, an estimated $106K.
  • Rotella Capital Management first reported a position in BIND THERAPEUTICS INC in Q2 2015 and held it in 1 quarter.
  • Rotella Capital Management's BIND THERAPEUTICS INC position peaked at $106K in Q2 2015.
  • 33 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.